Royal Bank Of Canada Has Lowered Expectations for Versigent (NYSE:VGNT) Stock Price

Key Points

• Royal Bank of Canada cut its Versigent price target from $53 to $52 but maintained an “outperform” rating; its new target implies 28.17% upside from the prior close.
• Analyst sentiment remains broadly positive: MarketBeat reports a “Moderate Buy” consensus and a $55 average price target, with 11 Buy, two Hold, and one Sell rating.
• Versigent beat quarterly estimates, reporting EPS of $1.91 versus $1.79 expected and revenue of $2.45 billion versus $2.42 billion expected. Shares nevertheless fell 3.3% on Thursday to $40.57.

Versigent (NYSE:VGNT - Get Free Report) had its target price reduced by equities researchers at Royal Bank Of Canada from $53.00 to $52.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an "outperform" rating on the stock. Royal Bank Of Canada's target price suggests a potential upside of 28.17% from the company's previous close.

Other research analysts have also issued research reports about the stock. Argus upped their price target on shares of Versigent from $50.00 to $54.00 and gave the company a "buy" rating in a research note on Thursday, August 13th. Fox Advisors lowered shares of Versigent from an "overweight" rating to an "equal weight" rating in a report on Wednesday, August 5th. Oppenheimer set a $50.00 target price on Versigent in a research report on Tuesday, July 21st. The Goldman Sachs Group lowered their price target on Versigent from $59.00 to $58.00 and set a "buy" rating for the company in a research report on Tuesday, October 6th. Finally, Zacks Research downgraded Versigent from a "hold" rating to a "strong sell" rating in a research note on Thursday, October 15th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $55.00.

Versigent Stock Down 3.3%

VGNT stock traded down $1.40 on Thursday, hitting $40.57. 586,927 shares of the company's stock were exchanged, compared to its average volume of 1,521,932. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88. The firm has a 50 day moving average price of $45.08 and a two-hundred day moving average price of $42.71. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40. The stock has a market cap of $2.87 billion and a P/E ratio of 21.09.

Versigent (NYSE:VGNT - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $1.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.12. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.42 billion. As a group, equities research analysts expect that Versigent will post 7.23 EPS for the current fiscal year.

Insider Buying and Selling at Versigent

In related news, Director Kevin Clark sold 47,761 shares of the firm's stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $44.36, for a total transaction of $2,118,677.96. Following the completion of the transaction, the director owned 27,571 shares of the company's stock, valued at $1,223,049.56. This trade represents a 63.40% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold a total of 220,000 shares of company stock valued at $10,065,848 in the last quarter.

Institutional Investors Weigh In On Versigent

Several hedge funds and other institutional investors have recently added to or reduced their stakes in VGNT. Allianz Asset Management GmbH acquired a new stake in Versigent during the second quarter valued at $20,602,000. HBK Investments L P acquired a new position in shares of Versigent in the second quarter worth about $14,439,000. VIRGINIA RETIREMENT SYSTEMS ET Al raised its position in shares of Versigent by 321.3% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 242,425 shares of the company's stock worth $10,895,000 after acquiring an additional 184,888 shares during the period. Steamboat Capital Partners LLC purchased a new stake in shares of Versigent during the 2nd quarter worth about $10,385,000. Finally, WINTON GROUP Ltd purchased a new stake in shares of Versigent during the 2nd quarter worth about $8,397,000.

More Versigent News

Here are the key news stories impacting Versigent this week:

• Positive Sentiment: Versigent reported third-quarter sales of $2.45 billion, up 7.2% year over year, and adjusted EPS of $1.91, above the $1.79 consensus estimate. Revenue also topped forecasts of $2.42 billion. Versigent Reports Third Quarter 2026 Results
• Positive Sentiment: The company announced a quarterly dividend of $0.13 per share, equivalent to $0.52 annually and a yield of about 1.2%.
• Neutral Sentiment: BNP Paribas Exane reaffirmed its “outperform” rating and kept a $54 target, implying potential upside from the current share price, but lowered the target from $55. BNP Paribas Exane rating information
• Neutral Sentiment: CFO Doug Ostermann is scheduled to speak at the RBC Capital Markets Global Industrials Conference on November 17. The appearance may provide investors with updates but is not itself a change to the company’s outlook. Versigent CFO conference announcement
• Negative Sentiment: Despite the 7.2% rise in reported sales, adjusted net sales growth was approximately 1% year over year. That more subdued underlying growth may have tempered the market’s response to the earnings beat.

About Versigent

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.